Glenmede Trust Co. NA Has $137.07 Million Stake in Procter & Gamble Company (The) $PG

Glenmede Trust Co. NA lowered its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 948,978 shares of the company’s stock after selling 33,640 shares during the quarter. Procter & Gamble accounts for approximately 0.7% of Glenmede Trust Co. NA’s portfolio, making the stock its 29th largest position. Glenmede Trust Co. NA’s holdings in Procter & Gamble were worth $137,070,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC increased its stake in Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. boosted its position in shares of Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after purchasing an additional 277 shares in the last quarter. Sivia Capital Partners LLC boosted its position in shares of Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after purchasing an additional 1,016 shares in the last quarter. Auxano Advisors LLC grew its stake in shares of Procter & Gamble by 10.8% in the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after buying an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. increased its position in Procter & Gamble by 2.8% in the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after buying an additional 809 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

PG stock opened at $144.62 on Friday. The company has a market capitalization of $336.77 billion, a P/E ratio of 21.85, a price-to-earnings-growth ratio of 7.20 and a beta of 0.39. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.53 and a current ratio of 0.68. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The business has a 50-day simple moving average of $147.71 and a two-hundred day simple moving average of $148.92.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.25% and a net margin of 18.44%.The firm had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. During the same period in the prior year, the business posted $1.48 earnings per share. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Research analysts expect that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Friday, July 24th will be issued a dividend of $1.0885 per share. The ex-dividend date is Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is 65.71%.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. TD Cowen upped their price target on Procter & Gamble from $142.00 to $150.00 and gave the stock a “hold” rating in a research note on Monday, April 27th. Jefferies Financial Group raised their price objective on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Raymond James Financial decreased their price objective on Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a report on Tuesday, April 14th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $163.00 target price on shares of Procter & Gamble in a research report on Monday, April 27th. Finally, Citigroup reduced their price target on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research report on Thursday. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $161.52.

Check Out Our Latest Stock Analysis on Procter & Gamble

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Citigroup maintained a Buy rating and set a $170 price target, implying substantial potential upside from recent levels, although the target was reduced from $181. Procter & Gamble Given New $170 Price Target at Citigroup
  • Positive Sentiment: Brokerage coverage still leans constructive, with PG receiving an average “Moderate Buy” rating; Jefferies also retained its Buy rating despite trimming its target to $177. PG Average Rating of Moderate Buy
  • Positive Sentiment: Management is emphasizing innovation, productivity improvements, e-commerce growth and market-share gains to support a consumer recovery. New product and marketing initiatives, including Downy’s premium fragrance campaign, could help reinforce brand strength. PG Q4 Earnings Call Highlights

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.